Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Ms. Sumi ShrishrimalExec. VP & Chief Risk Officer | -1,72k | 185,65k | Vendita | 108,19 | 40,29k | -4,09% |
| 2026-05-11 | Mr. Abhijit Y. TalwalkarIndependent Chairman | 5,31k | 56,89k | Automatic Acquisition | 10,71 | 18,94k | 38,98% |
| 2026-05-11 | Mr. Abhijit Y. TalwalkarIndependent Chairman | -5,31k | 569,54k | Derivative Exercise and Sale | 10,71 - 120,53 | 18,94k | - |
| 2026-05-04 | Mr. Brian LawrenceExec. VP & CTO | -1,01k | 122,49k | Vendita | 120,80 | 20,15k | -4,79% |
| 2026-03-16 | Mr. Mervin SmithExec. VP of Business Operations | -2,59k | 295,47k | Automatic Disposition | 114,30 | 5,77k | -30,96% |
| 2026-03-02 | Dr. Minang P. TurakhiaChief Medical & Scientific Officer and Exec. VP of Advanced Technologies | -4,03k | 517,26k | Vendita | 128,45 | 25,23k | -13,77% |
| 2026-03-02 | Ms. Sumi ShrishrimalExec. VP & Chief Risk Officer | -2,83k | 363,48k | Vendita | 128,44 | 41,87k | -6,33% |
| 2026-03-02 | Mr. Mervin SmithExec. VP of Business Operations | -1,35k | 173,65k | Vendita | 128,44 | 8,35k | -13,94% |
| 2026-03-02 | Mr. Chad M. PattersonChief Commercial and Product Officer | -4,44k | 570,80k | Vendita | 128,44 | 24,90k | -15,14% |
| 2026-03-02 | Mr. Patrick Michael MurphyChief Business & Legal Officer | -4,36k | 559,62k | Vendita | 128,44 - 128,45 | 63,20k | -6,45% |
| 2026-03-02 | Mr. Marc RosenbaumSenior VP of Finance & CAO | -816,00 | 104,81k | Vendita | 128,45 | 7,50k | -9,81% |
| 2026-03-02 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -3,40k | 436,08k | Vendita | 128,44 - 128,45 | 35,76k | -8,67% |
| 2026-03-02 | Mr. Quentin S. BlackfordPresident, CEO & Director | -13,81k | 1,77M | Vendita | 128,44 | 120,70k | -10,27% |
| 2026-02-25 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -5,19k | 702,55k | Vendita | 135,42 | 30,79k | -14,42% |
| 2026-02-25 | Dr. Minang P. TurakhiaChief Medical & Scientific Officer and Exec. VP of Advanced Technologies | -7,80k | 1,06M | Vendita | 135,42 | 22,85k | -25,46% |
| 2026-02-25 | Mr. Mervin SmithExec. VP of Business Operations | -4,04k | 547,23k | Vendita | 135,42 | 6,68k | -37,71% |
| 2026-02-25 | Ms. Sumi ShrishrimalExec. VP & Chief Risk Officer | -6,22k | 841,90k | Vendita | 135,42 | 39,18k | -13,69% |
| 2026-02-25 | Mr. Marc RosenbaumSenior VP of Finance & CAO | -4,80k | 649,60k | Vendita | 135,42 | 6,78k | -41,44% |
| 2026-02-25 | Mr. Chad M. PattersonChief Commercial and Product Officer | -8,97k | 1,21M | Vendita | 135,42 | 20,96k | -29,96% |
| 2026-02-25 | Mr. Patrick Michael MurphyChief Business & Legal Officer | -7,81k | 1,06M | Vendita | 135,42 | 60,54k | -11,42% |
| 2026-02-25 | Mr. Quentin S. BlackfordPresident, CEO & Director | -25,54k | 3,46M | Vendita | 135,42 | 109,94k | -18,85% |
| 2026-02-24 | Mr. Marc RosenbaumSenior VP of Finance & CAO | -280,00 | 39,45k | Automatic Disposition | 140,91 | 2,37k | -10,58% |
| 2026-02-24 | Mr. Mervin SmithExec. VP of Business Operations | -732,00 | 103,15k | Automatic Disposition | 140,91 | 1,51k | -32,69% |
| 2026-02-23 | Mr. Abhijit Y. TalwalkarIndependent Chairman | -5,31k | 717,09k | Derivative Exercise and Sale | 10,71 - 147,62 | 18,94k | - |
| 2025-12-02 | Mr. Chad M. PattersonChief Commercial and Product Officer | -280,00 | 51,75k | Automatic Disposition | 184,83 | 12,61k | -2,17% |
| 2025-12-02 | Mr. Patrick Michael MurphyChief Business & Legal Officer | -2,48k | 458,01k | Vendita | 184,83 | 53,28k | -4,44% |
| 2025-11-10 | Mr. Abhijit Y. TalwalkarIndependent Chairman | -5,31k | 868,07k | Derivative Exercise and Sale | 10,71 - 177,85 | 18,94k | - |
| 2025-11-03 | Mr. Quentin S. BlackfordPresident, CEO & Director | -14,06k | 2,57M | Vendita | 182,94 | 88,79k | -13,67% |
| 2025-10-31 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -8,00k | 1,66M | Automatic Disposition | 207,44 | 26,57k | -23,14% |
| 2025-09-03 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -5,00k | 875,00k | Automatic Disposition | 175,00 | 34,57k | -12,64% |
| 2025-09-02 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -737,00 | 123,29k | Vendita | 167,28 | 39,57k | -1,83% |
| 2025-08-22 | Ms. Sumi ShrishrimalExec. VP & Chief Risk Officer | -653,00 | 109,13k | Automatic Disposition | 167,12 | 34,03k | -1,88% |
| 2025-08-11 | Mr. Marc RosenbaumSenior VP of Finance & CAO | -226,00 | 35,92k | Automatic Disposition | 158,93 | 2,64k | -7,87% |
| 2025-08-11 | Mr. Abhijit Y. TalwalkarIndependent Chairman | -5,31k | 782,49k | Derivative Exercise and Sale | 10,71 - 158,68 | 18,94k | - |
| 2025-08-06 | Mr. Chad M. PattersonChief Commercial and Product Officer | -2,56k | 406,17k | Automatic Disposition | 158,97 | 12,89k | -16,54% |
| 2025-08-05 | Mr. Quentin S. BlackfordPresident, CEO & Director | -30,00k | 4,82M | Automatic Disposition | 158,85 - 165,00 | 102,85k | -22,58% |
| 2025-08-04 | Mr. Mervin SmithExec. VP of Business Operations | -616,00 | 101,25k | Vendita | 164,36 | 2,24k | -21,58% |
| 2025-08-04 | Mr. Chad M. PattersonChief Commercial and Product Officer | -2,71k | 444,92k | Vendita | 164,36 | 15,45k | -14,91% |
| 2025-07-02 | Dr. Minang P. TurakhiaChief Medical & Scientific Officer and Exec. VP of Advanced Technologies | -1,42k | 206,48k | Vendita | 145,41 | 15,34k | -8,47% |
| 2025-06-23 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -3,00k | 450,00k | Automatic Disposition | 150,00 | 40,31k | -6,93% |
| 2025-06-23 | Mr. Chad M. PattersonChief Commercial and Product Officer | -936,00 | 140,40k | Automatic Disposition | 150,00 | 12,89k | -6,77% |
| 2025-06-10 | Mr. Chad M. PattersonChief Commercial and Product Officer | -363,00 | 54,45k | Automatic Disposition | 150,00 | 13,83k | -2,56% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
